RankingsPricing
  1. JP-listed companies
  2. Takeda Pharmaceutical Company Limited
  3. Financials
  4. Total non-current liabilities

Takeda Pharmaceutical Company Limited【JP:4502】

Market cap
¥8.08T
P/E ratio
52.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal non-current liabilities (Million JPY)YoY (%)
Mar 31, 20254,805,844-12.96%
Mar 31, 20245,521,684+7.82%
Mar 31, 20235,121,138-4.26%
Mar 31, 20225,348,764-10.28%
Mar 31, 20215,961,940+0.75%
Mar 31, 20205,917,710-4.52%
Mar 31, 20196,197,803+495.44%
Mar 31, 20181,040,884+57.38%
Mar 31, 2017661,381+10.56%
Mar 31, 2016598,224-5.83%
Mar 31, 2015635,231

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)